Sir Michael Rawlins, chairman of the U.K.'s Institute for Health and Clinical Excellence (NICE), observes that NICE has "increased the new drugs available to patients and patients are getting a lot of benefit from it....So we're not saving anybody any money, we’re just making sure the money is well spent
Sir Michael Rawlins on Comparative Effectiveness in the U.K.
![michael-rawlins Michael Rawlins](/sites/default/files/styles/hero_image_desktop/public/images/___media_images_multimedia_2009_jul_michael_rawlins.gif?itok=JqJLq3AD)